Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery

Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link. We believe the chronic inflammation present in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity surgery 2003-02, Vol.13 (1), p.49-57
Hauptverfasser: Cottam, D R, Schaefer, P A, Shaftan, G W, Angus, L D G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 57
container_issue 1
container_start_page 49
container_title Obesity surgery
container_volume 13
creator Cottam, D R
Schaefer, P A
Shaftan, G W
Angus, L D G
description Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link. We believe the chronic inflammation present in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Leukocytes from 25 patients having gastric bypass surgery were compared to 15 normal controls preoperatively and at 1, 3, 6, and 12 months postoperatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. The percentage of CD95 + T cells was significantly elevated from controls (69.4% vs 56%, P = 0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P = 0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P = 0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naiveT cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P = 0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.
doi_str_mv 10.1381/096089203321136584
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73095030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2221361151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-ec29b2ddec9277e3f83f873272ad2ba0d1617daf05cd5ca403b5f2880d9ae6593</originalsourceid><addsrcrecordid>eNplkEtLxDAUhYMoOj7-gAsJLtxVb26maepOfIPgRtclTW6GSB9j0gr993ZwQFC4cDbfOXA_xk4FXAqpxRWUCnSJICUKIVWulztsIQrQGSxR77LFBshmQh6ww5Q-AFAoxH12IFBJUEIumL2bkh87O4S-Mw0PbTt2lK1j-AoNrYiHjrd9rIPjfU0pDNP1zKybYM2mkbjpHCfvyQ6893xl0hCD5fW0NinxNMYVxemY7XnTJDrZ5hF7f7h_u33KXl4fn29vXjIrUQ0ZWSxrdI5siUVB0uv5CokFGoe1ASeUKJzxkFuXW7MEWecetQZXGlJ5KY_Yxc_uOvafI6WhakOy1DSmo35MVSGhzEHCDJ7_AT_6Mc7_p0qjgBJVXswQ_kA29ilF8tVspTVxqgRUG__Vf_9z6Wy7PNYtud_KVrj8BkSkgUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>821092657</pqid></control><display><type>article</type><title>Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Cottam, D R ; Schaefer, P A ; Shaftan, G W ; Angus, L D G</creator><creatorcontrib>Cottam, D R ; Schaefer, P A ; Shaftan, G W ; Angus, L D G</creatorcontrib><description>Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link. We believe the chronic inflammation present in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Leukocytes from 25 patients having gastric bypass surgery were compared to 15 normal controls preoperatively and at 1, 3, 6, and 12 months postoperatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. The percentage of CD95 + T cells was significantly elevated from controls (69.4% vs 56%, P = 0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P = 0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P = 0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naiveT cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P = 0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.</description><identifier>ISSN: 0960-8923</identifier><identifier>EISSN: 1708-0428</identifier><identifier>DOI: 10.1381/096089203321136584</identifier><identifier>PMID: 12630613</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Adolescent ; Adult ; Antigens, CD - metabolism ; Antigens, Differentiation, T-Lymphocyte - metabolism ; Cancer ; Causality ; Comorbidity ; Fas Ligand Protein ; fas Receptor - metabolism ; Female ; Gastric Bypass ; Gastrointestinal surgery ; Humans ; Immune system ; Immunology ; L-Selectin - metabolism ; Lectins, C-Type ; Male ; Membrane Glycoproteins - metabolism ; Middle Aged ; Neoplasms - epidemiology ; Obesity, Morbid - epidemiology ; Obesity, Morbid - immunology ; Obesity, Morbid - surgery ; Retrospective Studies</subject><ispartof>Obesity surgery, 2003-02, Vol.13 (1), p.49-57</ispartof><rights>Springer 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-ec29b2ddec9277e3f83f873272ad2ba0d1617daf05cd5ca403b5f2880d9ae6593</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12630613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cottam, D R</creatorcontrib><creatorcontrib>Schaefer, P A</creatorcontrib><creatorcontrib>Shaftan, G W</creatorcontrib><creatorcontrib>Angus, L D G</creatorcontrib><title>Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery</title><title>Obesity surgery</title><addtitle>Obes Surg</addtitle><description>Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link. We believe the chronic inflammation present in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Leukocytes from 25 patients having gastric bypass surgery were compared to 15 normal controls preoperatively and at 1, 3, 6, and 12 months postoperatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. The percentage of CD95 + T cells was significantly elevated from controls (69.4% vs 56%, P = 0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P = 0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P = 0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naiveT cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P = 0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antigens, CD - metabolism</subject><subject>Antigens, Differentiation, T-Lymphocyte - metabolism</subject><subject>Cancer</subject><subject>Causality</subject><subject>Comorbidity</subject><subject>Fas Ligand Protein</subject><subject>fas Receptor - metabolism</subject><subject>Female</subject><subject>Gastric Bypass</subject><subject>Gastrointestinal surgery</subject><subject>Humans</subject><subject>Immune system</subject><subject>Immunology</subject><subject>L-Selectin - metabolism</subject><subject>Lectins, C-Type</subject><subject>Male</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Middle Aged</subject><subject>Neoplasms - epidemiology</subject><subject>Obesity, Morbid - epidemiology</subject><subject>Obesity, Morbid - immunology</subject><subject>Obesity, Morbid - surgery</subject><subject>Retrospective Studies</subject><issn>0960-8923</issn><issn>1708-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNplkEtLxDAUhYMoOj7-gAsJLtxVb26maepOfIPgRtclTW6GSB9j0gr993ZwQFC4cDbfOXA_xk4FXAqpxRWUCnSJICUKIVWulztsIQrQGSxR77LFBshmQh6ww5Q-AFAoxH12IFBJUEIumL2bkh87O4S-Mw0PbTt2lK1j-AoNrYiHjrd9rIPjfU0pDNP1zKybYM2mkbjpHCfvyQ6893xl0hCD5fW0NinxNMYVxemY7XnTJDrZ5hF7f7h_u33KXl4fn29vXjIrUQ0ZWSxrdI5siUVB0uv5CokFGoe1ASeUKJzxkFuXW7MEWecetQZXGlJ5KY_Yxc_uOvafI6WhakOy1DSmo35MVSGhzEHCDJ7_AT_6Mc7_p0qjgBJVXswQ_kA29ilF8tVspTVxqgRUG__Vf_9z6Wy7PNYtud_KVrj8BkSkgUQ</recordid><startdate>200302</startdate><enddate>200302</enddate><creator>Cottam, D R</creator><creator>Schaefer, P A</creator><creator>Shaftan, G W</creator><creator>Angus, L D G</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>200302</creationdate><title>Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery</title><author>Cottam, D R ; Schaefer, P A ; Shaftan, G W ; Angus, L D G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-ec29b2ddec9277e3f83f873272ad2ba0d1617daf05cd5ca403b5f2880d9ae6593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antigens, CD - metabolism</topic><topic>Antigens, Differentiation, T-Lymphocyte - metabolism</topic><topic>Cancer</topic><topic>Causality</topic><topic>Comorbidity</topic><topic>Fas Ligand Protein</topic><topic>fas Receptor - metabolism</topic><topic>Female</topic><topic>Gastric Bypass</topic><topic>Gastrointestinal surgery</topic><topic>Humans</topic><topic>Immune system</topic><topic>Immunology</topic><topic>L-Selectin - metabolism</topic><topic>Lectins, C-Type</topic><topic>Male</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Middle Aged</topic><topic>Neoplasms - epidemiology</topic><topic>Obesity, Morbid - epidemiology</topic><topic>Obesity, Morbid - immunology</topic><topic>Obesity, Morbid - surgery</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cottam, D R</creatorcontrib><creatorcontrib>Schaefer, P A</creatorcontrib><creatorcontrib>Shaftan, G W</creatorcontrib><creatorcontrib>Angus, L D G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cottam, D R</au><au>Schaefer, P A</au><au>Shaftan, G W</au><au>Angus, L D G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery</atitle><jtitle>Obesity surgery</jtitle><addtitle>Obes Surg</addtitle><date>2003-02</date><risdate>2003</risdate><volume>13</volume><issue>1</issue><spage>49</spage><epage>57</epage><pages>49-57</pages><issn>0960-8923</issn><eissn>1708-0428</eissn><abstract>Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link. We believe the chronic inflammation present in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Leukocytes from 25 patients having gastric bypass surgery were compared to 15 normal controls preoperatively and at 1, 3, 6, and 12 months postoperatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. The percentage of CD95 + T cells was significantly elevated from controls (69.4% vs 56%, P = 0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P = 0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P = 0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naiveT cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P = 0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>12630613</pmid><doi>10.1381/096089203321136584</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-8923
ispartof Obesity surgery, 2003-02, Vol.13 (1), p.49-57
issn 0960-8923
1708-0428
language eng
recordid cdi_proquest_miscellaneous_73095030
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adolescent
Adult
Antigens, CD - metabolism
Antigens, Differentiation, T-Lymphocyte - metabolism
Cancer
Causality
Comorbidity
Fas Ligand Protein
fas Receptor - metabolism
Female
Gastric Bypass
Gastrointestinal surgery
Humans
Immune system
Immunology
L-Selectin - metabolism
Lectins, C-Type
Male
Membrane Glycoproteins - metabolism
Middle Aged
Neoplasms - epidemiology
Obesity, Morbid - epidemiology
Obesity, Morbid - immunology
Obesity, Morbid - surgery
Retrospective Studies
title Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A24%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dysfunctional%20immune-privilege%20in%20morbid%20obesity:%20implications%20and%20effect%20of%20gastric%20bypass%20surgery&rft.jtitle=Obesity%20surgery&rft.au=Cottam,%20D%20R&rft.date=2003-02&rft.volume=13&rft.issue=1&rft.spage=49&rft.epage=57&rft.pages=49-57&rft.issn=0960-8923&rft.eissn=1708-0428&rft_id=info:doi/10.1381/096089203321136584&rft_dat=%3Cproquest_cross%3E2221361151%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=821092657&rft_id=info:pmid/12630613&rfr_iscdi=true